IBS - Irritable Bowel Syndrome: Clinical Trials

2 trials for IBS - Irritable Bowel Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Not yet recruiting 1, Recruiting 1

Follow IBS - Irritable Bowel Syndrome: new trials by email Literature Review of IBS - Irritable Bowel Syndrome trials Research Report on IBS - Irritable Bowel Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)
Psilocybin 25 mg, Psychotherapy Treatment Session, Niacin 100 mg - IBS - Irritable Bowel Syndrome
Early Phase 1Not yet recruitingNYU Langone Health102026-08-012026-03-05
Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator
Mirtazapine, Placebo - IBS - Irritable Bowel Syndrome, Diarrhea
Early Phase 1RecruitingMayo Clinic202024-12-192025-12-18

Narrower conditions

Irritable Bowel Syndrome (2)  ·  Diarrhea (1)

Broader conditions

Colonic Diseases (2)  ·  Colonic Diseases, Functional (2)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Mirtazapine (1)  ·  Niacin (1)  ·  Psilocybin (1)

Sponsors

Mayo Clinic (1)  ·  NYU Langone Health (1)

Countries

United States (2)

Top investigators

Brian E Lacy, MD (1)  ·  Maysaa El Zoghbi (1)